Transparency
of Clinical Study Information

Teva complies with international guidelines and regulations fundamental to clinical research and drug development, including the Declaration of Helsinki and the ICH Guidelines on Good Clinical Practice (GCP). Our focus on compliance ensures our clinical trials are well designed and carefully conducted to support the participants enrolled in them. Additionally, we are committed to ensuring our clinical trials comply with all global regulations regarding clinical trial registrations and results disclosures.

Teva is committed to the public disclosure of clinical trial results for our Innovative products.

Global registries – After the completion of an applicable clinical trial, results are provided on ClinicalTrials.gov, EU Clinical Trials Register, and EU Clinical Trials Information System within the timelines required by regulations.

Clinical study report synopses - Available clinical study report synopses will be shared on our clinical trial website in the Clinical Trials & Results section.

Plain language summaries - Available plain language summaries will be shared on our clinical trial website in the Clinical Trials & Results section.

Peer-reviewed journals – Teva submits clinical trial results for publication in peer-reviewed journals, per industry commitments.

Data sharing with qualified researchers – Teva evaluates requests for access to clinical trial data from external researchers.